MIF通过Mincle激活M1巨噬细胞介导急性肾损伤的机制研究

基本信息
批准号:81900673
项目类别:青年科学基金项目
资助金额:22.00
负责人:李金红
学科分类:
依托单位:中山大学
批准年份:2019
结题年份:2022
起止时间:2020-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:
关键词:
巨噬细胞迁移抑制因子M1巨噬细胞NFκB急性肾损伤Mincle
结项摘要

Acute kidney injury is a common critical disease and has a poor outcome. However, its mechanism remains unclear. Inflammation plays an important role in maintaining tubular injury after AKI. We have recently reported that macrophage migration inhibitory factor (MIF) plays a pathogenic role in AKI as genetic or chemical blockade of MIF protected against AKI in mice, and this was associated with the inhibition of M1 macrophages activation. What is the mechanism by which MIF promotes M1 macrophages activation? This is a problem need further investigation. A novel observation from our preliminary studies is that Mincle is a key membrane protein for triggering and maintaining the M1 macrophage activation in AKI. Our preliminary study found that: Mincle-expressing M1 macrophages were largely reduced in MIF knockout (KO) mice; In vitro study revealed that, MIF enhances Mincle expression in bone marrow derived macrophages (BMDM), siRNA knockdown of Mincle suppressed MIF induced M1 macrophage activation in BMDM, which was associated with Mincle-NF-κB-Syk suppression. We thus hypothesized that MIF may mediate AKI by activating M1 macrophages via the Mincle-NF-κB-Syk. This hypothesis will be examined by using approaches such as generating AKI model in macrophage specific Mincle knockout mice and MIF stimulation in bone marrow derived macrophages. We expect to find evidence that MIF directly activates M1 macrophages through the Mincle-NF-κB-Syk in AKI. These results may lead to development of MIF and/or Mincle as potential novel targets for effective treatment of AKI.

急性肾损伤(Acute Kidney Injury, AKI)是组临床常见危重急症,机制不清。巨噬细胞M1活化是AKI加重的重要因素。既往研究发现基因或药物阻断MIF减轻AKI,与MIF促进M1活化相关,但MIF如何激活M1机制尚不清楚。申请人前期研究证明Mincle是触发M1活化的关键膜蛋白,体内外预试验显示:AKI状态下MIF可增加巨噬细胞Mincle表达及M1活化;siRNA阻断Mincle可以抑制MIF对骨髓来源巨噬细胞M1的活化,且与NF-κB-Syk被抑制相关。因此,本研究提出MIF或可调节Mincle转录,通过NF-κB-Syk激活M1介导AKI的发生。项目拟在条件性敲除Mincle小鼠构建AKI模型再注射MIF的方法及体外实验,探索MIF通过Mincle介导M1活化促进AKI的分子机制。为临床通过阻断MIF介导的巨噬细胞激活及炎症反应来治疗AKI奠定理论基础。

项目摘要

急性肾损伤(Acute Kidney Injury, AKI)是组临床常见危重急症,机制不清。炎症是AKI加重的重要因素。我们研究发现基因或药物阻断MIF减轻AKI,与MIF促进M1巨噬细胞活化相关,但MIF如何激活M1机制尚不清楚。我们前期研究证明Mincle是触发M1活化的关键膜蛋白,而体内和体外预试验显示:MIF可增加巨噬细胞Mincle表达及M1活化;siRNA阻断Mincle可以抑制MIF对骨髓来源巨噬细胞M1的活化,且与NF-κB-Syk信号明确相关。因此,本研究提出MIF或可调节Mincle转录,通过NF-κB-Syk激活M1介导AKI的发生。本研究发现,基因敲除MIF小鼠发生AKI时,肾脏Mincle表达减少,Mincle阳性M1巨噬细胞减少;体外试验证实,MIF可以增加骨髓来源巨噬细胞的Mincle表达水平,且呈时间和剂量依赖性;siRNA阻断CD74表达可以抑制MIF诱导的Mincle表达,以及Mincle阳性M1巨噬细胞活化;阻断NF-κB可以阻断MIF诱导的Mincle表达,以及Mincle阳性M1巨噬细胞活化;NF-κB-Mincle-Syk 形成一个环路来促进MIF诱导的Mincle表达途径。切段NF-κB-Mincle-Syk从而减少MIF引起的Mincle表达以及M1巨噬细胞活化,或可为临床通过阻断MIF介导的炎症反应治疗AKI建立新方法提供新思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
2

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
3

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018
4

基于ESO的DGVSCMG双框架伺服系统不匹配 扰动抑制

基于ESO的DGVSCMG双框架伺服系统不匹配 扰动抑制

DOI:
发表时间:2018
5

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

DOI:10.1016/j.fitote.2020.104491
发表时间:2020

李金红的其他基金

批准号:11226036
批准年份:2012
资助金额:3.00
项目类别:数学天元基金项目

相似国自然基金

1

LRNA9884调控Mincle维持M1巨噬细胞表型:急性肾损伤后炎症释放的机制研究

批准号:81900622
批准年份:2019
负责人:张颖莹
学科分类:H0502
资助金额:20.00
项目类别:青年科学基金项目
2

Hedgehog通过Gli介导调控巨噬细胞极化影响急性肾损伤的分子机制

批准号:81772264
批准年份:2017
负责人:白永恒
学科分类:H2605
资助金额:56.00
项目类别:面上项目
3

mTOR调控急性缺血性肾损伤修复期M1/M2型巨噬细胞生物学活性的机制研究

批准号:81300566
批准年份:2013
负责人:陈国纯
学科分类:H0502
资助金额:23.00
项目类别:青年科学基金项目
4

SerpinC1/antithrombinIII 通过调控巨噬细胞极化抑制急性肾损伤-慢性肾脏病转化的分子机制

批准号:81770741
批准年份:2017
负责人:王锋
学科分类:H0505
资助金额:55.00
项目类别:面上项目